Month: September 2025

Editor's Note: With advancements in medicine, allogeneic hematopoietic cell transplantation (allo-HCT) has become a hope for a cure for many patients with high-risk hematologic malignancies. However, the high risks and…

Editor's Note: From June 12 to 15, 2025, the European Hematology Association (EHA) Annual Congress was held in Milan, Italy, bringing together top experts in the field of hematology from…

Editor's Note: At the 2025 European Hematology Association (EHA) Annual Congress, a dedicated guideline session was grandly held, bringing together top experts in the global hematology field. One of the…

Editor's Note: At the European Hematology Association (EHA) 2025 Annual Congress, the special session on Multiple Myeloma (MM) was filled to capacity. The core focus of the meeting was the…

Editor's Note: During the 2025 European Hematology Association (EHA) Annual Meeting, a session on the interpretation of the new Peripheral T-Cell Lymphoma (PTCL) guidelines drew significant attention. At this session,…